Detalhe da pesquisa
1.
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.
Blood
; 140(17): 1845-1857, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35917453
2.
Clinicogenomic factors and treatment patterns among patients with advanced non-small cell lung cancer with or without brain metastases in the United States.
Oncologist
; 28(11): e1075-e1091, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358877
3.
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults.
Blood
; 125(12): 1857-65, 2015 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25624319
4.
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.
Blood
; 123(17): 2645-51, 2014 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24627528
5.
Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations.
Am J Hematol
; 91(4): 406-9, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26799334
6.
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.
Haematologica
; 100(9): 1117-30, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341525
7.
Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes.
Curr Opin Hematol
; 21(2): 131-40, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24378705
8.
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.
Blood
; 119(14): 3203-10, 2012 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22323480
9.
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes.
Blood
; 120(25): 4945-51, 2012 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22915641
10.
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.
Blood
; 120(16): 3173-86, 2012 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22826563
11.
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.
Blood
; 119(25): 6109-17, 2012 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22553315
12.
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
Haematologica
; 99(5): 821-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24463215
13.
Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options.
Ann Hematol
; 93(12): 1965-76, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25270596
14.
Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia.
Am J Hematol
; 89(2): 168-73, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24123154
15.
Sex differences in the incidence of chronic myeloid leukemia.
Radiat Environ Biophys
; 53(1): 55-63, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24337217
16.
SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.
Blood
; 117(25): 6876-84, 2011 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21527527
17.
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
Blood
; 117(17): 4552-60, 2011 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21285439
18.
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.
Blood
; 118(14): 3932-41, 2011 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21828135
19.
Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia.
Haematologica
; 98(1): 107-13, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22773603
20.
Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.
Am J Hematol
; 88(10): 906-9, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23828018